Post-earnings recap
Reported
Thu, May 9, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ICU Med Inc reported a strong EPS performance, beating expectations by over 10%. However, the stock fell by 2.01% in reaction, likely due to the absence of revenue figures and guidance. Investors may be concerned about the lack of clarity on future performance, which contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.58 | N/A | +10.74% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They acknowledged the challenges ahead but emphasized their commitment to improving operations.
Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.
They highlighted ongoing initiatives to enhance operational efficiency.